Linfo CD30+

🇺🇸 United States
Takeda Pharmaceuticals  | 
14
ASO score
Text
25/100
Reviews
0/100
Graphic
12/100
Other
0/100
rating
App Rating
rating
Votes
rating
App Age
3y 5m
rating
Last Update
Aug 04, 2022

Compare with Category Top Apps

Metrics
Current App
Category Top Average
Difference
Installs
55
36.3M
-100%
Rating
0
4.55
Number of Ratings (Voted)
0
49.8M
App Age
3y 5m
7y 4m
-53%
In-app Purchases Price
$0
$63
Update Frequency
1256d
143d
+779%
Title Length
11
27
-59%
Short Description Length
0
70
Description Length
0
3 229
Number of Screenshots
258
1034
-75 %
Has Video?
No
0% has videos
Size
18MB
0MB

Category Ranking in United States

All
New
Trending Up
Trending Down
Top Jan 03, 2026 Jan 10, 2026
No results were found!
Top Jan 03, 2026 Jan 10, 2026
No results were found!
Top Jan 03, 2026 Jan 10, 2026
No results were found!
Top Jan 03, 2026 Jan 10, 2026
No results were found!

Text ASO

Title (
Characters: 11 of 50
)
Linfo CD30+
Short Description (
Characters: 77 of 80
)
Información para médicos sobre el uso del tratamiento con Brentuximab Vedotin
Description (
Characters: 423 of 4000
)
Aplicación diseñada por Takeda Argentina con el propósito de crear un nuevo canal de comunicación con los especialistas, quienes, por medio de esta herramienta, tendrán a su disposición información relevante sobre Adcetris (Brentuximab Vedotin), así como las últimas novedades relacionadas con el uso del tratamiento. Esta APP se caracterizará por brindar contenidos y propuestas de valor agregado innovadoras y atractivas.}

Visual ASO

Screenshots

Rating & Reviews

Reviews Overview
🧐 Coming Soon…
Rating
0
0 voters

Some Latest Reviews

Other

Additional Information
😢 Deleted from App Store
Rating:
0
Voted: 0
Google Play Link:
Website: -
Email: -
Privacy Policy:
Categories: Health & Fitness
Size: 18MB
App Age: 3 years 5 months
Release Date: Aug 04, 2022
Last Update: Aug 04, 2022
Version: 1.0.5
Version history
1.0.5
Aug 04, 2022